Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
No evidence package for common commercial routes FDAs briefing found no adequate human studies for the commonly proposed oral, subcutaneous, nasal, or transdermal routes
They noted extended support hours as a positive but docked points for the lack of published response time guarantees
This comparison breaks down how they differ for menopause, PCOS, hormonal health, weight loss, insurance, pricing, and ongoing provider support
PMID 1418040
US$ 26.21
US$ 20.46
US$ 26.74
US$ 22.88
US$ 24.09
